Everything below concerns drug affinity complex. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-29. Numbers and descriptions here follow the published literature rather than marketing material.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The Bradford assay uses the spectral properties of Coomassie brilliant blue G-250 to estimate the amount of protein in a solution. A protein sample is added to a solution of the dye in phosphoric acid and ethanol. Under the acid conditions the dye is normally a brownish colour but on binding to the protein the blue form of the dye is produced. The optical absorbance of the solution is measured at a wavelength of 595 nm. The dye is noted for its high level of sensitivity: 5 μg of protein can be detected. However, among the disadvantages of the method is its variability of color development with different proteins: the absorbance change per unit mass of proteins varies with the type of the protein. On binding to a protein, the negatively charged Coomassie brilliant blue G-250 dye molecule will give an overall negative charge to the protein. This property can be used to separate proteins or protein complexes using polyacrylamide gel electrophoresis under non-denaturing conditions in a technique called blue native PAGE. The mobility of the complex in the polyacrylamide gel will depend on both the size of the protein complex (i.e., the molecular weight) and the amount of dye bound to the protein. Coomassie blue staining can also be used as a loading control staining method in western blot analysis. It is applied as an anionic pre-antibody stain.
The exchanging lipids contain disulfide bonds as well as diacylglycerol groups that are not necessarily present in the host membranes. Studies provide evidence through monolayer measurements, condensing properties, and nearly identical gel to liquid-crystalline phase transition temperatures (Tm) to the host membranes that the presence of these bonds do not play a major role or interfere in the recognition or packing formation of the modeled membranes in the presence of ethanol. The disulfide bonds, diacylglycerol bonds, and similar sterol framework are only present to mimic the physical properties of DSPC, DPPC, and cholesterol as well as aid in the monomer exchanging processes to form exchangeable dimers. The exchangeable lipids undergo a monomer interchanging process through the disulfide bridges in which they either mix ideally, homogenously, or heterogeneously. Their interactions are measured by the equilibrium constant (K) which will be described in further detail under the significance of results section. Overall, the monomer interchanging process is necessary in order to demonstrate the nearest neighbor recognition technique effective by observing changes in the phase composition of the host membranes/phospholipids. Each model membrane consists of a high concentration of one of the host membranes/phospholipids (95% mol %), low concentrations of two exchanging lipids (2.5 mol% each for a total of 5%), varied mole percentages of cholesterol (0–30 mol %) plus a constant concentration of ethanol (5% v/v).
=== Glyoxylate scenario === Eschenmoser also proposed a parallel scenario where the connections between prebiotic reactions would be connected by glyoxylate, a simple α-ketoacid, produced by HCN oligomerization and hydrolysis. In this work, Eschenmoser proposes potential schemes to generate both informational oligomers and other key autocatalytic reactions from plausible one-carbon sources (HCN, CO, CO2). The Krishnamurthy group at Scripps experimentally expanded on this theory. In mild aqueous conditions, they demonstrated that the reaction of glyoxylate and pyruvate can produce a series of α-ketoacid intermediates constituting the reductive tricarboxylic acid (TCA) cycle. This reaction proceeded without metal or enzyme catalysts as glyoxylate acted as both the carbon source and reducing agent in the reaction. Similarly, the Moran group have also reported pyruvate and glyoxylate can react in warm iron-rich water to produce TCA intermediates and some amino acids. Their work has successfully reconstructed 9 out of 11 TCA intermediates and 5 universal metabolic precursors. Additional experimental analysis is needed to connect this scenario to modern metabolism.
{\displaystyle {\begin{aligned}V=\left[H_{0}^{1}(\Omega )\right]^{d}&=\left\{\mathbf {v} \in \left[H^{1}(\Omega )\right]^{d}:\quad \mathbf {v} =\mathbf {0} {\text{ on }}\Gamma _{D}\right\},\\Q&=L^{2}(\Omega )\end{aligned}}}
In the wake of the rebel capture of Damascus, several places in the capital were ransacked, including Iran's embassy, Assad's estates, and government offices; the Central Bank of Syria was besieged and the reception hall of the Presidential Palace was set on fire. Statues of Hafez al-Assad were toppled nationwide. The Russian and Chinese embassies were untouched. The rebels announced a 13-hour curfew in the capital amidst heavy armed rebel presence and traffic in the capital. Syrian State Television, now under rebel control, resumed broadcasting. Al-Assad clan members expressed resentment over the escape of Bashar and his close family, with one relative stating that "Everyone feels he betrayed them". Israel bombed the Mezzeh Air Base in Damascus. Another strike targeted an alleged Iranian research center used for missile development in the Kafr Sousa district. The Israeli army also crossed the border into Syria, seizing territory adjacent to the border after it was abandoned by the Syrian Army. HTS leader Ahmed al-Sharaa became the de facto leader of Syria on 8 December 2024 as the General Commander and head of the New Syrian Administration, serving until 29 January 2025, when he was appointed President of Syria by the Syrian General Command. Mohammed al-Bashir, head of the Syrian Salvation Government, was appointed prime minister of the Syrian caretaker government on 10 December and served until 29 March 2025.
Sources: en.wikipedia.org
=== Nutrient delivery system === Immunoliposomes can also be used as nutrient delivery systems to help stimulate brain activity. The effective transport of certain nutrients to the hypothalamus in order to regulate brain activity is currently a huge problem. The leptin gene is used to regulate feedback loops and send signals from the adipose tissue to the hypothalamus. Using this physiological function of leptin, immunoliposome nutrient delivery systems can be integrated into the body to help with nutrition transport to the brain as seen in Figure 5. Transferrin receptors have high expression at the BBB (blood brain barrier) and can be used as targets for immunoliposomes to transport p-glycoprotein substances.
Optical spectrometry, a technique for measuring the distribution of light across the optical spectrum, from the ultraviolet spectral region to the visible and infrared Ion-mobility spectrometry, an analytical technique used to separate and identify ionized molecules in the gas phase based on their ion mobility in a carrier buffer gas Mass spectrometry, an analytical technique that measures the mass-to-charge ratio of charged particles Rutherford backscattering spectrometry, an analytical technique used to determine the structure and composition of materials by measuring the back-scattering of a beam of high energy ions impinging on a sample Neutron triple-axis spectrometry, a technique used in inelastic neutron scattering Gamma-spectrometry, a method used to acquire a quantitative gamma-spectrum measurement Nuclear magnetic resonance spectroscopy, a technique that uses radio frequency pulses and a magnetic field to study the properties of atomic nuclei.
Storage can be short-term or long-term. Most vegetables are perishable and short-term storage for a few days provides flexibility in marketing. During storage, leafy vegetables lose moisture, and the vitamin C in them degrades rapidly. A few products such as potatoes and onions have better keeping qualities and can be sold when higher prices may be available, and by extending the marketing season, a greater total volume of crop can be sold. If refrigerated storage is not available, the priority for most crops is to store high-quality produce, to maintain a high humidity level, and to keep the produce in the shade. Proper post-harvest storage aimed at extending and ensuring shelf life is best effected by efficient cold chain application. Cold storage is particularly useful for vegetables such as cauliflower, eggplant, lettuce, radish, spinach, potatoes, and tomatoes, the optimum temperature depending on the type of produce. There are temperature-controlling technologies that do not require the use of electricity such as evaporative cooling. Storage of fruit and vegetables in controlled atmospheres with high levels of carbon dioxide or high oxygen levels can inhibit microbial growth and extend storage life. The irradiation of vegetables and other agricultural produce by ionizing radiation can be used to preserve it from both microbial infection and insect damage, as well as from physical deterioration. It can extend the storage life of food without noticeably changing its properties.
In the mid-to-late 1980s, the crack epidemic followed widespread cocaine use in American cities. The death rate was worse, reaching almost 2 per 100,000. In 1982, Vice President George H. W. Bush and his aides began pushing for the involvement of the CIA and the US military in drug interdiction efforts, the so-called war on drugs. The initial promotion and marketing of OxyContin was an organized effort throughout 1996–2001, to dismiss the risk of opioid addiction. Purdue Pharma hosted over forty promotional conferences at three select locations in the southwest and southeast of the United States. Coupling a convincing "Partners Against Pain" campaign with an incentivized bonus system, Purdue trained its salesforce to convey the message that the risk of addiction was under one percent, ultimately influencing the prescribing habits of the medical professionals that attended these conferences. Consulting firm McKinsey & Company reached a nearly $600 million settlement with 49 of 50 U.S. states in 2021 over the firm's role in driving opioid sales for Purdue Pharma and other pharmaceutical companies. In 2016, the opioid epidemic was killing on average 10.3 people per 100,000, with the highest rates including over 30 per 100,000 in New Hampshire and over 40 per 100,000 in West Virginia. Purdue heavily promoted oxycodone, increasing their earning to US$35 billion by 2017. The owners, the Sackler family, were nevertheless able to file for bankruptcy afterwards.
=== Golden Grove Mansion Appeal === Since Healing the Wounds' foundation, the charity campaigned to raise funds to purchase and maintain a convalescent home based at Golden Grove Mansion in Llandeilo, Carmarthenshire. However, by January 2011 the condition of Golden Grove had deteriorated to such an extent that it would not have been financially viable to renovate and maintain the mansion as a retreat for PTSD sufferers. Nevertheless, Healing the Wounds remains devoted to the development of a convalescent home within Wales and the £120,000 raised through the campaign shall be spent on treatment for those suffering from PTSD.
Sources: en.wikipedia.org
==== Malaysia ==== The Chicken Rice Shop Sushi King Kuai Lee Gee Happy Chicken Marrybrown Pelita Nasi Kandar Rotiboy Kedai Mee Celup Cik Yue Sate Kajang Haji Samuri Ramly Restoran Shah Maju NZ Curry House SCR Pak Mat Western Secret Recipe
Matrikines are a large and somewhat loosely defined group of peptides and small proteins, encompassing both endogenous signalling factors important in wound healing and tissue remodeling, and synthetically produced versions of these along with related analogues and derivatives, which are used mainly for cosmetic applications as well as for scientific research and with some medical indications.
Harmful effects on the ecosystem caused by HABs include water deoxygenation, production of toxins that deter competing species and grazers. Certain species of algae have been observed to produce paralytic toxins targeting shellfish which can greatly disrupt coastal ecosystems as well as commercial fisheries. Algicidal bacteria have been studied as biological control agents for inhibiting the formation of harmful algal blooms. They may also help protect aquaculture operations, improve water treatment processes, and contribute to the restoration of phytoplankton community balance in aquatic ecosystems.
=== Ber–Bla === Paul Berg (1926–2023), American biochemist known for research on nucleic acids, especially recombinant DNA, 1980 Nobel Prize in Chemistry Friedrich Bergius (1884–1949), German chemist known for known for production of synthetic fuel from coal, 1931 Nobel Prize in Chemistry Helen M. Berman (born 1943), American chemist who worked on structural analysis of protein-nucleic acid complexes Marcellin Berthelot (1827–1907), French chemist, a prominent anti-vitalist who synthesized many organic compounds from inorganic substances, and developed thermochemistry Claude Louis Berthollet (1748–1822), French chemist who developed the theory of chemical equilibria Carolyn R. Bertozzi (born 1966) American chemist who studies chemical reactions compatible with living systems ("bioorthogonal chemistry"), 2022 Nobel Prize in Chemistry Guy Bertrand (born 1952) French chemist working on carbenes, nitrenes, phosphinidenes, radicals and biradicals Jöns Jakob Berzelius (1779–1848), Swedish chemist who discovered several elements Johannes Martin Bijvoet (1892–1980), Dutch chemist and crystallographer who determined the absolute configuration of sodium rubidium tartrate Leonora Bilger (1893–1975), American chemist who studied nitrogenous compounds Katherine Bitting (1869–1937), Canadian and American food chemist for the United States Department of Agriculture and the National Canners Association Joseph Black (1728–1799), British chemist known for discoveries of magnesium, latent heat, specific heat, and carbon dioxide
== Lecturer == From 2005 to 2013, he served as a neurophysiology researcher at the University of Ulm.[23] In 2014, he received a lifelong appointment as Visiting Professor at the Instituto Universitario de Ciencias de la Salud, Buenos Aires.[17] Since 2019, Schleip has been a Research Associate and, since 2024, a Senior Scientist at the professorship of conservative and rehabilitative orthopaedics in the TUM School of Medicine & Health at the Technical University of Munich.[23]
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.